Stavros Manolagas
Concepts (408)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bone and Bones | 38 | 2023 | 516 | 6.670 |
Why?
| Osteoblasts | 44 | 2022 | 514 | 5.960 |
Why?
| Estrogens | 20 | 2022 | 244 | 3.970 |
Why?
| Osteoclasts | 35 | 2023 | 469 | 3.950 |
Why?
| Osteoporosis | 15 | 2021 | 164 | 3.560 |
Why?
| Osteocytes | 20 | 2015 | 220 | 3.050 |
Why?
| Bone Density | 29 | 2023 | 416 | 2.850 |
Why?
| Estrogen Receptor alpha | 8 | 2016 | 95 | 2.730 |
Why?
| Apoptosis | 28 | 2020 | 1300 | 2.610 |
Why?
| Aging | 18 | 2021 | 784 | 2.430 |
Why?
| Glucocorticoids | 10 | 2017 | 234 | 2.390 |
Why?
| Bone Remodeling | 14 | 2020 | 177 | 2.160 |
Why?
| Oxidative Stress | 15 | 2018 | 958 | 2.070 |
Why?
| Mice | 74 | 2023 | 6413 | 1.940 |
Why?
| Animals | 90 | 2023 | 14385 | 1.870 |
Why?
| Androgens | 6 | 2017 | 68 | 1.870 |
Why?
| Osteogenesis | 18 | 2023 | 377 | 1.680 |
Why?
| Signal Transduction | 20 | 2020 | 1753 | 1.660 |
Why?
| Bone Resorption | 14 | 2020 | 326 | 1.640 |
Why?
| Wnt Proteins | 10 | 2016 | 110 | 1.620 |
Why?
| Bone Diseases, Metabolic | 5 | 2022 | 82 | 1.560 |
Why?
| Cell Differentiation | 18 | 2020 | 720 | 1.400 |
Why?
| Forkhead Transcription Factors | 8 | 2016 | 118 | 1.330 |
Why?
| Stem Cells | 11 | 2019 | 193 | 1.330 |
Why?
| Parathyroid Hormone | 7 | 2010 | 196 | 1.270 |
Why?
| Gonadal Steroid Hormones | 4 | 2016 | 42 | 1.150 |
Why?
| Prednisolone | 4 | 2011 | 57 | 1.140 |
Why?
| Receptors, Androgen | 4 | 2015 | 49 | 1.110 |
Why?
| Mice, Inbred C57BL | 28 | 2019 | 1999 | 1.110 |
Why?
| RANK Ligand | 16 | 2023 | 183 | 1.090 |
Why?
| Calcification, Physiologic | 3 | 2020 | 42 | 0.980 |
Why?
| Wnt Signaling Pathway | 4 | 2016 | 94 | 0.950 |
Why?
| Chemokine CXCL12 | 2 | 2020 | 31 | 0.880 |
Why?
| Matrix Metalloproteinase 13 | 1 | 2022 | 10 | 0.870 |
Why?
| beta Catenin | 5 | 2014 | 102 | 0.860 |
Why?
| Ovariectomy | 7 | 2022 | 125 | 0.830 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 7 | 2010 | 101 | 0.830 |
Why?
| Periosteum | 2 | 2012 | 20 | 0.780 |
Why?
| Female | 50 | 2022 | 28441 | 0.770 |
Why?
| Hydrogen Peroxide | 5 | 2016 | 142 | 0.730 |
Why?
| Alkaline Phosphatase | 1 | 2020 | 99 | 0.720 |
Why?
| Transcription, Genetic | 11 | 2015 | 418 | 0.710 |
Why?
| Cell Nucleus | 4 | 2013 | 203 | 0.700 |
Why?
| Gene Deletion | 9 | 2020 | 293 | 0.680 |
Why?
| Reactive Oxygen Species | 9 | 2018 | 491 | 0.660 |
Why?
| Estradiol | 6 | 2013 | 219 | 0.630 |
Why?
| Femur Head Necrosis | 1 | 2017 | 17 | 0.630 |
Why?
| Femur Head | 1 | 2017 | 27 | 0.620 |
Why?
| Osteonecrosis | 1 | 2017 | 36 | 0.620 |
Why?
| Cells, Cultured | 17 | 2020 | 1737 | 0.590 |
Why?
| Femur | 9 | 2016 | 144 | 0.590 |
Why?
| Shc Signaling Adaptor Proteins | 3 | 2011 | 27 | 0.580 |
Why?
| Biochemistry | 1 | 2015 | 5 | 0.540 |
Why?
| Osteoprotegerin | 3 | 2016 | 57 | 0.530 |
Why?
| Male | 29 | 2022 | 27334 | 0.500 |
Why?
| Mice, Transgenic | 16 | 2021 | 656 | 0.490 |
Why?
| Enzyme Activation | 9 | 2015 | 329 | 0.490 |
Why?
| Humans | 40 | 2023 | 54284 | 0.490 |
Why?
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2014 | 22 | 0.470 |
Why?
| bcl-2-Associated X Protein | 1 | 2014 | 73 | 0.470 |
Why?
| Mice, Knockout | 13 | 2022 | 926 | 0.470 |
Why?
| Fractures, Spontaneous | 1 | 2013 | 19 | 0.470 |
Why?
| Porosity | 4 | 2017 | 34 | 0.460 |
Why?
| Spinal Fractures | 1 | 2013 | 41 | 0.450 |
Why?
| Steroids | 1 | 2013 | 53 | 0.450 |
Why?
| Models, Biological | 10 | 2015 | 823 | 0.450 |
Why?
| Cell Lineage | 5 | 2016 | 93 | 0.430 |
Why?
| Cell Count | 6 | 2020 | 181 | 0.420 |
Why?
| Homeodomain Proteins | 3 | 2022 | 82 | 0.410 |
Why?
| NF-kappa B | 4 | 2017 | 335 | 0.400 |
Why?
| Transcription Factors | 8 | 2013 | 622 | 0.400 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2016 | 434 | 0.390 |
Why?
| TCF Transcription Factors | 2 | 2007 | 11 | 0.390 |
Why?
| Phospholipids | 2 | 2021 | 63 | 0.390 |
Why?
| Dexamethasone | 3 | 2011 | 435 | 0.380 |
Why?
| Homeostasis | 4 | 2017 | 223 | 0.380 |
Why?
| Alendronate | 3 | 2009 | 20 | 0.380 |
Why?
| Spine | 6 | 2016 | 111 | 0.380 |
Why?
| Orchiectomy | 2 | 2015 | 38 | 0.370 |
Why?
| Protein Kinase C | 1 | 2010 | 65 | 0.370 |
Why?
| Pain | 1 | 2013 | 405 | 0.370 |
Why?
| Bone Diseases | 2 | 2010 | 109 | 0.360 |
Why?
| Muscle, Skeletal | 2 | 2015 | 847 | 0.360 |
Why?
| Hyperparathyroidism | 2 | 2011 | 50 | 0.360 |
Why?
| Disease Models, Animal | 2 | 2016 | 1639 | 0.350 |
Why?
| Cell Line | 10 | 2011 | 1153 | 0.350 |
Why?
| Neovascularization, Physiologic | 1 | 2009 | 72 | 0.350 |
Why?
| Menopause | 1 | 2010 | 61 | 0.350 |
Why?
| Water | 1 | 2009 | 102 | 0.350 |
Why?
| Mitosis | 2 | 2008 | 106 | 0.340 |
Why?
| Mitogen-Activated Protein Kinases | 4 | 2015 | 169 | 0.330 |
Why?
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2008 | 10 | 0.330 |
Why?
| Organ Size | 4 | 2016 | 237 | 0.330 |
Why?
| Receptors, Estrogen | 2 | 2006 | 131 | 0.330 |
Why?
| Interleukin-6 | 4 | 2016 | 315 | 0.320 |
Why?
| Calcium | 5 | 2014 | 432 | 0.320 |
Why?
| Bone Density Conservation Agents | 1 | 2009 | 83 | 0.320 |
Why?
| Membrane Glycoproteins | 3 | 2006 | 269 | 0.320 |
Why?
| Mitochondria | 3 | 2021 | 489 | 0.310 |
Why?
| Phosphorylation | 7 | 2010 | 614 | 0.310 |
Why?
| Cholesterol | 1 | 2008 | 155 | 0.310 |
Why?
| Estrenes | 2 | 2006 | 12 | 0.310 |
Why?
| Gene Expression Regulation | 8 | 2020 | 1062 | 0.310 |
Why?
| Phosphatidylinositol 3-Kinases | 2 | 2005 | 153 | 0.300 |
Why?
| Carrier Proteins | 3 | 2006 | 359 | 0.300 |
Why?
| Osteoporosis, Postmenopausal | 1 | 2006 | 36 | 0.290 |
Why?
| Glucose | 2 | 2016 | 366 | 0.290 |
Why?
| Nerve Tissue Proteins | 1 | 2008 | 199 | 0.280 |
Why?
| Blotting, Western | 7 | 2016 | 683 | 0.280 |
Why?
| JNK Mitogen-Activated Protein Kinases | 2 | 2007 | 78 | 0.270 |
Why?
| Scavenger Receptors, Class B | 2 | 2023 | 10 | 0.270 |
Why?
| X-Ray Microtomography | 5 | 2016 | 82 | 0.260 |
Why?
| Receptors, Calcitriol | 1 | 2005 | 21 | 0.260 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2005 | 39 | 0.260 |
Why?
| Calcitriol | 1 | 2005 | 40 | 0.260 |
Why?
| Sirtuin 1 | 2 | 2015 | 29 | 0.260 |
Why?
| Bone Development | 3 | 2014 | 69 | 0.260 |
Why?
| src-Family Kinases | 1 | 2005 | 54 | 0.250 |
Why?
| Hormone Replacement Therapy | 1 | 2004 | 27 | 0.250 |
Why?
| Enhancer Elements, Genetic | 3 | 2011 | 64 | 0.250 |
Why?
| Vesicular Transport Proteins | 2 | 2016 | 43 | 0.240 |
Why?
| RNA | 3 | 2023 | 202 | 0.240 |
Why?
| Pseudohypoparathyroidism | 1 | 2003 | 1 | 0.240 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2016 | 673 | 0.240 |
Why?
| Cell Proliferation | 5 | 2018 | 1096 | 0.230 |
Why?
| Integrases | 4 | 2016 | 45 | 0.220 |
Why?
| Adipogenesis | 2 | 2020 | 52 | 0.220 |
Why?
| Stress, Mechanical | 3 | 2013 | 96 | 0.220 |
Why?
| Reproducibility of Results | 2 | 2018 | 1304 | 0.210 |
Why?
| Oxidation-Reduction | 5 | 2020 | 382 | 0.210 |
Why?
| Osteocalcin | 2 | 2020 | 46 | 0.210 |
Why?
| Diphosphonates | 3 | 2008 | 96 | 0.200 |
Why?
| Adenosine Triphosphate | 2 | 2020 | 242 | 0.200 |
Why?
| Sirtuin 3 | 1 | 2021 | 17 | 0.200 |
Why?
| Up-Regulation | 3 | 2010 | 508 | 0.190 |
Why?
| Monocyte-Macrophage Precursor Cells | 1 | 2020 | 8 | 0.190 |
Why?
| Gene Expression Regulation, Enzymologic | 3 | 2014 | 206 | 0.190 |
Why?
| Bone Marrow Cells | 3 | 2015 | 233 | 0.190 |
Why?
| Gene Knock-In Techniques | 2 | 2010 | 30 | 0.190 |
Why?
| Oxidative Phosphorylation | 1 | 2020 | 57 | 0.180 |
Why?
| DNA-Binding Proteins | 1 | 2003 | 462 | 0.180 |
Why?
| Cell Division | 2 | 2015 | 330 | 0.180 |
Why?
| Cell Survival | 6 | 2012 | 657 | 0.180 |
Why?
| Atherosclerosis | 2 | 2016 | 249 | 0.170 |
Why?
| RNA, Messenger | 6 | 2010 | 1202 | 0.170 |
Why?
| Transfection | 6 | 2007 | 399 | 0.170 |
Why?
| Connexin 43 | 4 | 2008 | 23 | 0.170 |
Why?
| MAP Kinase Kinase 4 | 2 | 2011 | 34 | 0.170 |
Why?
| Bone Morphogenetic Proteins | 2 | 2010 | 64 | 0.160 |
Why?
| Bone Morphogenetic Protein 2 | 2 | 2010 | 51 | 0.160 |
Why?
| Ligands | 5 | 2007 | 230 | 0.160 |
Why?
| Immunoglobulin M | 1 | 2018 | 65 | 0.160 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2011 | 176 | 0.160 |
Why?
| Single-Chain Antibodies | 1 | 2018 | 28 | 0.160 |
Why?
| Epitopes | 1 | 2018 | 89 | 0.160 |
Why?
| Biological Evolution | 1 | 2018 | 37 | 0.160 |
Why?
| Phenotype | 4 | 2015 | 820 | 0.150 |
Why?
| Cyclic AMP Response Element-Binding Protein | 3 | 2013 | 34 | 0.150 |
Why?
| Lipid Metabolism | 2 | 2009 | 194 | 0.150 |
Why?
| Adaptor Proteins, Signal Transducing | 3 | 2016 | 208 | 0.150 |
Why?
| Myeloid Cells | 1 | 2016 | 37 | 0.150 |
Why?
| rab GTP-Binding Proteins | 1 | 2016 | 39 | 0.140 |
Why?
| Lysosomes | 1 | 2016 | 91 | 0.140 |
Why?
| HeLa Cells | 4 | 2005 | 291 | 0.140 |
Why?
| Quantitative Trait Loci | 2 | 2006 | 51 | 0.140 |
Why?
| Autophagy | 2 | 2015 | 202 | 0.140 |
Why?
| Apolipoproteins E | 1 | 2016 | 62 | 0.130 |
Why?
| Protein Structure, Tertiary | 3 | 2007 | 289 | 0.130 |
Why?
| Gene Expression | 4 | 2023 | 664 | 0.130 |
Why?
| History, 21st Century | 1 | 2015 | 62 | 0.130 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2016 | 140 | 0.130 |
Why?
| Absorptiometry, Photon | 4 | 2016 | 174 | 0.130 |
Why?
| Body Weight | 2 | 2010 | 578 | 0.130 |
Why?
| History, 20th Century | 1 | 2015 | 114 | 0.130 |
Why?
| Microtubule-Associated Proteins | 2 | 2013 | 78 | 0.130 |
Why?
| Aorta | 1 | 2016 | 177 | 0.130 |
Why?
| Sarcopenia | 1 | 2015 | 83 | 0.130 |
Why?
| Time Factors | 6 | 2008 | 3213 | 0.130 |
Why?
| Calcium, Dietary | 1 | 2014 | 15 | 0.120 |
Why?
| National Institutes of Health (U.S.) | 1 | 2014 | 49 | 0.120 |
Why?
| Lumbar Vertebrae | 2 | 2013 | 105 | 0.120 |
Why?
| Catalase | 1 | 2014 | 74 | 0.120 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2016 | 202 | 0.120 |
Why?
| FMN Reductase | 1 | 2013 | 3 | 0.120 |
Why?
| Cytoplasm | 2 | 2004 | 108 | 0.120 |
Why?
| Plasmids | 2 | 2004 | 180 | 0.120 |
Why?
| Fracture Healing | 1 | 2013 | 26 | 0.120 |
Why?
| Atrophy | 1 | 2013 | 40 | 0.110 |
Why?
| Mice, Mutant Strains | 1 | 2012 | 84 | 0.110 |
Why?
| Cell Cycle Proteins | 2 | 2013 | 199 | 0.110 |
Why?
| Uterus | 1 | 2013 | 98 | 0.110 |
Why?
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 2 | 2009 | 12 | 0.110 |
Why?
| Dose-Response Relationship, Drug | 2 | 2009 | 1476 | 0.110 |
Why?
| Bone Marrow | 2 | 2013 | 411 | 0.110 |
Why?
| Organ Specificity | 2 | 2010 | 126 | 0.110 |
Why?
| Bone Demineralization, Pathologic | 1 | 2011 | 5 | 0.110 |
Why?
| Research Design | 1 | 2014 | 374 | 0.110 |
Why?
| Iron | 1 | 2013 | 158 | 0.110 |
Why?
| Dyneins | 1 | 2011 | 9 | 0.100 |
Why?
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2011 | 10 | 0.100 |
Why?
| Bone Matrix | 1 | 2011 | 20 | 0.100 |
Why?
| Lactation | 1 | 2011 | 61 | 0.100 |
Why?
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 21 | 0.100 |
Why?
| Macrophages | 2 | 2016 | 405 | 0.100 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 3 | 2006 | 32 | 0.100 |
Why?
| B-Lymphocytes | 1 | 2012 | 176 | 0.100 |
Why?
| PPAR gamma | 2 | 2009 | 79 | 0.100 |
Why?
| Solubility | 1 | 2010 | 75 | 0.100 |
Why?
| Membrane Proteins | 1 | 2013 | 389 | 0.100 |
Why?
| Linear Models | 2 | 2009 | 309 | 0.090 |
Why?
| Smad1 Protein | 1 | 2010 | 6 | 0.090 |
Why?
| Genes, Reporter | 2 | 2017 | 98 | 0.090 |
Why?
| Genetic Markers | 1 | 2010 | 117 | 0.090 |
Why?
| Oxidants | 1 | 2010 | 64 | 0.090 |
Why?
| Glutathione Reductase | 1 | 2010 | 15 | 0.090 |
Why?
| Turner Syndrome | 1 | 2010 | 14 | 0.090 |
Why?
| Chimera | 1 | 2010 | 13 | 0.090 |
Why?
| Green Fluorescent Proteins | 3 | 2005 | 110 | 0.090 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 122 | 0.090 |
Why?
| Glycoproteins | 1 | 2010 | 132 | 0.090 |
Why?
| Transgenes | 1 | 2010 | 55 | 0.090 |
Why?
| Gene Targeting | 1 | 2010 | 32 | 0.090 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 60 | 0.090 |
Why?
| Acid Phosphatase | 1 | 2009 | 15 | 0.090 |
Why?
| Cell Death | 1 | 2010 | 223 | 0.090 |
Why?
| Thymidine Kinase | 1 | 2008 | 20 | 0.080 |
Why?
| Skull | 2 | 2009 | 79 | 0.080 |
Why?
| Ganciclovir | 1 | 2008 | 35 | 0.080 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2009 | 230 | 0.080 |
Why?
| Receptors, Parathyroid Hormone | 1 | 2008 | 11 | 0.080 |
Why?
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2008 | 24 | 0.080 |
Why?
| Isoenzymes | 1 | 2009 | 177 | 0.080 |
Why?
| Multienzyme Complexes | 2 | 2009 | 41 | 0.080 |
Why?
| Cell Membrane | 2 | 2007 | 278 | 0.080 |
Why?
| Blotting, Northern | 2 | 2005 | 108 | 0.080 |
Why?
| Multipotent Stem Cells | 1 | 2007 | 4 | 0.080 |
Why?
| Collagen Type I | 1 | 2008 | 97 | 0.080 |
Why?
| Postmenopause | 1 | 2009 | 102 | 0.080 |
Why?
| Estrogen Antagonists | 2 | 2007 | 19 | 0.080 |
Why?
| Mutagenesis, Site-Directed | 1 | 2007 | 117 | 0.080 |
Why?
| DNA Replication | 1 | 2008 | 152 | 0.080 |
Why?
| Focal Adhesion Kinase 1 | 1 | 2007 | 15 | 0.080 |
Why?
| Hormones | 1 | 2007 | 59 | 0.080 |
Why?
| Anoikis | 1 | 2007 | 9 | 0.080 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 2 | 2004 | 56 | 0.080 |
Why?
| Focal Adhesion Kinase 2 | 1 | 2007 | 12 | 0.080 |
Why?
| Molecular Structure | 2 | 2006 | 319 | 0.080 |
Why?
| X Chromosome | 1 | 2006 | 13 | 0.070 |
Why?
| Dihydrotestosterone | 1 | 2006 | 14 | 0.070 |
Why?
| Extracellular Matrix | 1 | 2007 | 111 | 0.070 |
Why?
| Estrogen Receptor beta | 1 | 2007 | 56 | 0.070 |
Why?
| Smad Proteins | 1 | 2006 | 13 | 0.070 |
Why?
| Mechanotransduction, Cellular | 1 | 2007 | 35 | 0.070 |
Why?
| Response Elements | 1 | 2006 | 32 | 0.070 |
Why?
| Double-Blind Method | 1 | 2009 | 742 | 0.070 |
Why?
| MAP Kinase Signaling System | 1 | 2007 | 133 | 0.070 |
Why?
| Teriparatide | 1 | 2006 | 14 | 0.070 |
Why?
| Weightlessness | 1 | 2006 | 14 | 0.070 |
Why?
| Biopsy | 1 | 2009 | 692 | 0.070 |
Why?
| Proto-Oncogene Proteins | 2 | 2005 | 169 | 0.070 |
Why?
| Extracellular Matrix Proteins | 3 | 2014 | 75 | 0.070 |
Why?
| Kinetics | 2 | 2004 | 692 | 0.070 |
Why?
| Transforming Growth Factor beta | 1 | 2006 | 158 | 0.070 |
Why?
| Synteny | 1 | 2005 | 7 | 0.070 |
Why?
| Chromosomes, Human, X | 1 | 2005 | 21 | 0.070 |
Why?
| Histocytochemistry | 1 | 2005 | 46 | 0.070 |
Why?
| Lipoproteins, LDL | 2 | 2018 | 195 | 0.070 |
Why?
| Endosomes | 2 | 2016 | 37 | 0.070 |
Why?
| Chromosome Mapping | 1 | 2005 | 175 | 0.070 |
Why?
| Diet, High-Fat | 2 | 2018 | 216 | 0.060 |
Why?
| Cholera Toxin | 1 | 2004 | 16 | 0.060 |
Why?
| Protein Binding | 4 | 2011 | 736 | 0.060 |
Why?
| Adipocytes | 2 | 2004 | 129 | 0.060 |
Why?
| Active Transport, Cell Nucleus | 1 | 2004 | 45 | 0.060 |
Why?
| Antioxidants | 1 | 2007 | 297 | 0.060 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 55 | 0.060 |
Why?
| Fatty Acids, Unsaturated | 1 | 2004 | 46 | 0.060 |
Why?
| Etoposide | 1 | 2004 | 85 | 0.060 |
Why?
| Compressive Strength | 1 | 2004 | 11 | 0.060 |
Why?
| Seminal Vesicles | 1 | 2004 | 12 | 0.060 |
Why?
| Thiazolidinediones | 1 | 2004 | 95 | 0.060 |
Why?
| DNA Primers | 2 | 2014 | 225 | 0.060 |
Why?
| Nuclear Receptor Co-Repressor 1 | 1 | 2023 | 3 | 0.060 |
Why?
| Co-Repressor Proteins | 1 | 2023 | 17 | 0.060 |
Why?
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2003 | 4 | 0.060 |
Why?
| ets-Domain Protein Elk-1 | 1 | 2003 | 6 | 0.060 |
Why?
| Cysteine Endopeptidases | 1 | 2003 | 75 | 0.060 |
Why?
| Arachidonate 15-Lipoxygenase | 2 | 2016 | 17 | 0.060 |
Why?
| Arachidonate 12-Lipoxygenase | 2 | 2016 | 17 | 0.060 |
Why?
| Phosphotransferases | 1 | 2003 | 24 | 0.060 |
Why?
| Rats | 2 | 2008 | 3415 | 0.060 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2003 | 25 | 0.060 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2003 | 65 | 0.060 |
Why?
| Diabetes Mellitus | 1 | 2007 | 309 | 0.060 |
Why?
| United States | 1 | 2014 | 5217 | 0.060 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 2003 | 83 | 0.060 |
Why?
| Mice, 129 Strain | 2 | 2013 | 49 | 0.060 |
Why?
| Core Binding Factor Alpha 1 Subunit | 3 | 2009 | 48 | 0.050 |
Why?
| Immunoblotting | 2 | 2015 | 134 | 0.050 |
Why?
| Receptors, Scavenger | 1 | 2022 | 28 | 0.050 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 85 | 0.050 |
Why?
| Down-Regulation | 1 | 2003 | 388 | 0.050 |
Why?
| Mutation | 2 | 2007 | 1501 | 0.050 |
Why?
| Age Factors | 2 | 2020 | 1198 | 0.050 |
Why?
| Genitalia | 1 | 2001 | 15 | 0.050 |
Why?
| Luminescent Proteins | 2 | 2017 | 66 | 0.050 |
Why?
| Analysis of Variance | 2 | 2014 | 635 | 0.050 |
Why?
| DNA | 1 | 2005 | 581 | 0.050 |
Why?
| Cardiovascular System | 1 | 2001 | 50 | 0.050 |
Why?
| Radiography | 2 | 2013 | 524 | 0.050 |
Why?
| Neoplasm Proteins | 1 | 2003 | 359 | 0.050 |
Why?
| Central Nervous System | 1 | 2001 | 85 | 0.050 |
Why?
| Antibodies, Neutralizing | 1 | 2020 | 75 | 0.050 |
Why?
| Adult | 2 | 2009 | 14207 | 0.050 |
Why?
| Alleles | 2 | 2012 | 277 | 0.050 |
Why?
| Base Sequence | 2 | 2014 | 719 | 0.040 |
Why?
| Sex Characteristics | 1 | 2001 | 214 | 0.040 |
Why?
| Cattle | 2 | 2009 | 224 | 0.040 |
Why?
| GATA4 Transcription Factor | 1 | 2017 | 13 | 0.040 |
Why?
| G1 Phase Cell Cycle Checkpoints | 1 | 2017 | 21 | 0.040 |
Why?
| Primary Cell Culture | 1 | 2017 | 65 | 0.040 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2017 | 93 | 0.040 |
Why?
| Aniline Compounds | 1 | 2017 | 48 | 0.040 |
Why?
| Models, Animal | 1 | 2017 | 255 | 0.040 |
Why?
| Mice, Inbred BALB C | 1 | 2017 | 368 | 0.040 |
Why?
| Immunomagnetic Separation | 1 | 2016 | 9 | 0.040 |
Why?
| Genotype | 2 | 2008 | 599 | 0.030 |
Why?
| Embryo, Mammalian | 2 | 2009 | 68 | 0.030 |
Why?
| Species Specificity | 2 | 2006 | 205 | 0.030 |
Why?
| Sulfonamides | 1 | 2017 | 146 | 0.030 |
Why?
| Middle Aged | 2 | 2009 | 13088 | 0.030 |
Why?
| Heme Oxygenase-1 | 1 | 2015 | 21 | 0.030 |
Why?
| Acetylation | 1 | 2015 | 99 | 0.030 |
Why?
| Interleukin-1beta | 1 | 2016 | 92 | 0.030 |
Why?
| Monocytes | 1 | 2016 | 156 | 0.030 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2017 | 250 | 0.030 |
Why?
| Recombination, Genetic | 1 | 2015 | 108 | 0.030 |
Why?
| DNA Damage | 1 | 2017 | 357 | 0.030 |
Why?
| Histones | 1 | 2017 | 335 | 0.030 |
Why?
| Hyperthyroidism | 1 | 2014 | 27 | 0.030 |
Why?
| Gene Knockout Techniques | 1 | 2013 | 45 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 206 | 0.030 |
Why?
| Fibroblasts | 2 | 2009 | 386 | 0.030 |
Why?
| Gene Knockdown Techniques | 1 | 2013 | 125 | 0.030 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2006 | 552 | 0.030 |
Why?
| Flow Cytometry | 1 | 2016 | 546 | 0.030 |
Why?
| Fatty Acids | 2 | 2004 | 174 | 0.030 |
Why?
| Cathepsin K | 1 | 2011 | 7 | 0.030 |
Why?
| Histological Techniques | 1 | 2011 | 10 | 0.030 |
Why?
| Adiposity | 1 | 2013 | 142 | 0.030 |
Why?
| Chondrocytes | 1 | 2011 | 37 | 0.030 |
Why?
| Inflammation | 1 | 2016 | 674 | 0.020 |
Why?
| Oxandrolone | 1 | 2010 | 10 | 0.020 |
Why?
| Cartilage | 1 | 2010 | 47 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2011 | 531 | 0.020 |
Why?
| Body Height | 1 | 2010 | 76 | 0.020 |
Why?
| T-Lymphocytes | 1 | 2012 | 373 | 0.020 |
Why?
| Core Binding Factor beta Subunit | 1 | 2009 | 4 | 0.020 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 74 | 0.020 |
Why?
| Aldehydes | 1 | 2009 | 97 | 0.020 |
Why?
| Stromal Cells | 1 | 2009 | 79 | 0.020 |
Why?
| Gene Silencing | 1 | 2008 | 129 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2009 | 252 | 0.020 |
Why?
| Vitamin D | 1 | 2009 | 101 | 0.020 |
Why?
| Lymphoid Tissue | 1 | 2007 | 23 | 0.020 |
Why?
| Phosphoproteins | 1 | 2008 | 116 | 0.020 |
Why?
| Caveolin 1 | 1 | 2007 | 21 | 0.020 |
Why?
| Weight Gain | 1 | 2008 | 243 | 0.020 |
Why?
| Transcription Initiation Site | 1 | 2006 | 13 | 0.020 |
Why?
| Base Pairing | 1 | 2006 | 28 | 0.020 |
Why?
| Conserved Sequence | 1 | 2006 | 57 | 0.020 |
Why?
| Cyclic AMP | 1 | 2006 | 106 | 0.020 |
Why?
| Wnt3 Protein | 1 | 2005 | 8 | 0.020 |
Why?
| Wnt1 Protein | 1 | 2005 | 12 | 0.020 |
Why?
| Culture Media, Serum-Free | 1 | 2005 | 20 | 0.020 |
Why?
| Cycloheximide | 1 | 2005 | 32 | 0.020 |
Why?
| Wnt3A Protein | 1 | 2005 | 13 | 0.020 |
Why?
| Caspase 3 | 1 | 2006 | 135 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 2008 | 520 | 0.020 |
Why?
| Crosses, Genetic | 1 | 2005 | 31 | 0.020 |
Why?
| Culture Media | 1 | 2005 | 100 | 0.020 |
Why?
| Caspases | 1 | 2006 | 146 | 0.020 |
Why?
| Binding Sites | 1 | 2006 | 440 | 0.020 |
Why?
| Haplotypes | 1 | 2005 | 105 | 0.020 |
Why?
| Densitometry | 1 | 2004 | 17 | 0.020 |
Why?
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2004 | 8 | 0.020 |
Why?
| Mesoderm | 1 | 2004 | 33 | 0.020 |
Why?
| Molecular Sequence Data | 1 | 2006 | 980 | 0.020 |
Why?
| Drug Synergism | 1 | 2004 | 171 | 0.020 |
Why?
| Free Radical Scavengers | 1 | 2004 | 35 | 0.020 |
Why?
| Sex Factors | 1 | 2006 | 767 | 0.020 |
Why?
| Tensile Strength | 1 | 2003 | 33 | 0.020 |
Why?
| bcl-Associated Death Protein | 1 | 2003 | 13 | 0.010 |
Why?
| Dactinomycin | 1 | 2003 | 23 | 0.010 |
Why?
| Culture Media, Conditioned | 1 | 2003 | 52 | 0.010 |
Why?
| Acetylcysteine | 1 | 2004 | 118 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2006 | 570 | 0.010 |
Why?
| Hypoglycemic Agents | 1 | 2004 | 177 | 0.010 |
Why?
| Enzyme Inhibitors | 1 | 2005 | 446 | 0.010 |
Why?
| Models, Genetic | 1 | 2003 | 209 | 0.010 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2003 | 131 | 0.010 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 158 | 0.010 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2002 | 41 | 0.010 |
Why?
| src Homology Domains | 1 | 2001 | 9 | 0.010 |
Why?
| Chick Embryo | 1 | 2001 | 79 | 0.010 |
Why?
| Transcriptional Activation | 1 | 2002 | 134 | 0.010 |
Why?
| Adolescent | 1 | 2010 | 6897 | 0.010 |
Why?
| Child | 1 | 2010 | 7341 | 0.010 |
Why?
|
|
Manolagas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|